Stock Research for TTPH

TTPH

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

TTPH Stock Chart & Research Data

The TTPH chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TTPH chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


TTPH Due diligence Resources & Stock Charts

The TTPH stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View TTPH Detailed Price Forecast - CNN Money CNN View TTPH Detailed Summary - Google Finance
Yahoo View TTPH Detailed Summary - Yahoo! Finance Zacks View TTPH Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View TTPH Trends & Analysis - Trade-Ideas Barrons View TTPH Major Holders - Barrons
NASDAQ View TTPH Call Transcripts - NASDAQ Seeking View TTPH Breaking News & Analysis - Seeking Alpha
Spotlight View TTPH Annual Report - CompanySpotlight.com OTC Report View TTPH OTC Short Report - OTCShortReport.com
TradeKing View TTPH Fundamentals - TradeKing Charts View TTPH SEC Filings - Bar Chart
WSJ View Historical Prices for TTPH - The WSJ Morningstar View Performance/Total Return for TTPH - Morningstar
MarketWatch View the Analyst Estimates for TTPH - MarketWatch CNBC View the Earnings History for TTPH - CNBC
StockMarketWatch View the TTPH Earnings - StockMarketWatch MacroAxis View TTPH Buy or Sell Recommendations - MacroAxis
Bullish View the TTPH Bullish Patterns - American Bulls Short Pains View TTPH Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View TTPH Stock Mentions - StockTwits PennyStocks View TTPH Stock Mentions - PennyStockTweets
Twitter View TTPH Stock Mentions - Twitter Invest Hub View TTPH Investment Forum News - Investor Hub
Yahoo View TTPH Stock Mentions - Yahoo! Message Board Seeking Alpha View TTPH Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for TTPH - SECform4.com Insider Cow View Insider Transactions for TTPH - Insider Cow
CNBC View TTPH Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for TTPH - OTC Markets
Yahoo View Insider Transactions for TTPH - Yahoo! Finance NASDAQ View Institutional Holdings for TTPH - NASDAQ


Stock Charts

FinViz View TTPH Stock Insight & Charts - FinViz.com StockCharts View TTPH Investment Charts - StockCharts.com
BarChart View TTPH Stock Overview & Charts - BarChart Trading View View TTPH User Generated Charts - Trading View




Latest Financial News for TTPH


Tetraphase Pharmaceuticals Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Posted on Thursday July 12, 2018

Tetraphase Pharmaceuticals, Inc. (TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that Tetraphase's Compensation Committee of the Board of Directors approved, pursuant to NASDAQ Listing Rule 5635(c)(4), the grant of inducement equity awards in the form of stock options to four new employees to purchase an aggregate of 60,000 shares of Tetraphase's common stock. The options were granted as an inducement equity awards outside Tetraphase's 2013 Stock Incentive Plan and were made as an inducement material to four new employee’s acceptance of employment with Tetraphase. The stock options have exercise prices equal to the closing price of Tetraphase's common stock on July 13, 2018.


Breakfast Technical Briefing on Tetraphase Pharma and Three Other Additional Biotech Stocks
Posted on Thursday July 12, 2018

LONDON, UK / ACCESSWIRE / July 12, 2018 / If you want a free Stock Review on TTPH sign up now at www.wallstequities.com/registration. Companies in the Biotechnology industry primarily use living organisms or molecular and cellular techniques to provide chemicals, food, and services that meet human needs.


Detailed Research: Economic Perspectives on Tetraphase Pharmaceuticals, Tech Data, Southern National Bancorp of Virginia, Esterline Technologies, Myers Industries, and Hersha Hospitality Trust — What Drives Growth in Today's Competitive Landscape
Posted on Thursday June 21, 2018

NEW YORK, June 21, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tetraphase ...


Tetraphase Pharmaceuticals Announces Data from a Pooled Analysis of IGNITE1 and IGNITE4 Phase 3 Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections at the ASM Microbe 2018 Annual Meeting
Posted on Monday June 11, 2018

Tetraphase Pharmaceuticals, Inc. (TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, recently reported data on eravacycline, which is currently under review by the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of complicated intra-abdominal infections (cIAI), as well as data for TP-6076, its second-generation candidate targeting MDR Gram-negative bacteria, which is currently in phase 1 clinical testing. “For the first time, we are sharing a pooled analysis of our IGNITE1 and IGNITE4 studies of eravacycline and are pleased to show that favorable clinical and microbiological responses were observed for eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including those demonstrating resistant phenotypes and genotypes such as MDR and extended spectrum beta-lactamase (ESBL) production,” said Guy Macdonald, President and Chief Executive Officer of Tetraphase.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.